Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline

Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that on June 3, 2025, it received notice from the Nasdaq Hearings Panel confirming compliance with the minimum bid price requirement under Listing Rule 5550(a)(2). The Panel also reminded the Company to meet the equity requirement in Listing Rule 5550(b)(1) by June 30, 2025, as per the granted extension. The Nasdaq Listing Qualifications process will remain open until the C…

Helius Medical Technologies Stock Tumbles Amid Listing Concerns

In a startling turn of events, shares of Helius Medical (HSDT) plunges 76.66% in premarket trading this morning, falling from $3.17 to just $0.74. The drop came just a day after the neurotech company announced it had regained compliance with Nasdaq’s minimum bid price rule – but warned it still must meet equity requirements by June 30 to remain listed. Despite recent progress, including a major reimbursement win from United Healthcare and promis…